NIH Schedules Closed Grant Review Meetings
Published Date: 6/25/2026
Notice
Summary
The NIH’s Center for Scientific Review is holding several closed virtual meetings on July 17, 2026, to review important grant applications. These meetings protect private info and trade secrets while deciding which science projects get funding. Researchers applying for grants in brain injury, neurobehavior, nanotech, and heart/lung studies should note these review dates and prepare accordingly.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 0 costs, 1 mixed.
NIH closed virtual grant review meetings
If you are a researcher applying for NIH grants in areas such as brain injury, neurobehavior, nanotechnology, cardiovascular/respiratory sciences, cancer therapeutics, or related topics, note that the Center for Scientific Review will hold closed virtual review meetings on July 17, 2026 and July 20–22, 2026 to evaluate grant applications. The meetings are closed to the public and will protect confidential trade secrets, patentable material, and personal information while reviewers decide funding.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-12842 — Government Owned Inventions Available for License: Compositions and Methods for Producing Dendritic Cell-based Vaccines With Enhanced Efficacy
The National Cancer Institute has created a new way to make cancer vaccines stronger by using special omega-3 fats to boost immune cells called dendritic cells. This could help scientists and companies develop better cancer treatments that work more effectively. If you’re in biotech or medicine, now’s the time to team up or license this exciting technology and help bring improved vaccines to patients faster.
2026-12843 — Government Owned Inventions Available for License: C8166-45 Cell Line
The National Cancer Institute is offering a special human T-cell line called C8166-45 for licensing. This cell line helps scientists study viruses like HTLV-1 and HIV, which can cause serious diseases. Researchers and companies can now use this tool to develop better treatments, with licensing info available starting June 2026—no patents, just pure science power ready to roll!
2026-12565 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for cool science projects. If you’re a researcher waiting on grants, these reviews shape the future of your funding and the science world!
2026-12585 — Submission for OMB Review; 30-Day Comment Request; Chimpanzee Research Use Form (Office of the Director)
The NIH wants to keep collecting info using the Chimpanzee Research Use Form and is asking the public to share thoughts by July 23, 2026. This form helps track how chimpanzees are used in research, affecting scientists and animal welfare groups. No big changes or costs are expected, just a smooth extension of the current form’s approval.
2026-12244 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide funding for health research projects. Scientists and researchers applying for grants should note these dates as they impact which projects get money.
2026-12116 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important grant applications. These meetings protect private info and trade secrets while helping fund research on mice, drug development, and primate centers. Scientists and research groups applying for grants should watch for these dates as they impact funding decisions.
Previous / Next Documents
Previous: 2026-12843 — Government Owned Inventions Available for License: C8166-45 Cell Line
The National Cancer Institute is offering a special human T-cell line called C8166-45 for licensing. This cell line helps scientists study viruses like HTLV-1 and HIV, which can cause serious diseases. Researchers and companies can now use this tool to develop better treatments, with licensing info available starting June 2026—no patents, just pure science power ready to roll!
Next: 2026-12845 — Change In Control: NFE Altamira FLNG, S. de R.L. de C.V.
NFE Altamira FLNG, S. de R.L. de C.V. is changing who’s in charge, which means new leaders will take over the company soon. This change affects the company’s control but doesn’t signal any immediate money shifts or deadlines. Everyone involved should keep an eye out for official updates as the switch happens.